Proactive, a digital financial news organization, will be showcasing four intrepid companies on the fast track to growth at its latest North American virtual investor conference.
The event will feature live webcast presentations and delegates will be given the opportunity to put their questions to the corporate presenters at a Q&A to be moderated by Proactive’s Christine Corrado.
Joining Proactive’s One2One Virtual Investor Forum at 1 pm ET on July 28 are:
- Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:AGNPF)
- Clean Seed Capital Group (CVE:CSX) (OTCMKTS:CLGPF)
- MamaMancini's Holdings Inc (OTCMKTS:MMMB)
- Alpine 4 Technologies Limited (OTCQB: ALPP)
Betting big on Ifenprodil
Algernon Pharmaceuticals has been nimble — and unusual — in its hunt for a coronavirus (COVID-19) drug. The company has taken a generic neurological drug that Sanofi developed in the 1970’s called Ifenprodil, which is approved for use in South Korea and Japan, and is attempting to repurpose it as a potential treatment.
The Vancouver-based clinical-stage pharmaceutical company is launching a multinational Phase 2b/3 human trial of its lead drug NP-120 (Ifenprodil) as a potential treatment for COVID-19 sufferers. Enrollment of the first patient for the multinational study is expected before the end of July 2020.
“It’s interesting that our lead drug NP-120 is a neurological drug that we are trying to repurpose for lung diseases,” Algeron Pharmaceuticals CEO Christopher J Moreau told Proactive.
“Interestingly, when we began this journey, we didn't know which of the 11 drugs we started investigating for new diseases would end up where we are today. Here we are with Ifenprodil as the lead,” added Moreau, who will talk about the company’s promising pipeline at the virtual investor event.
Algernon is also steadily advancing NP-120 (Ifenprodil) as a possible treatment for idiopathic pulmonary fibrosis, acute lung injury, and chronic cough. Additionally, the company is focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and inflammatory bowel disease (IBD). Algernon’s key compounds were identified using a drug repurposing strategy.
Clean Seed’s SMART farming technologies
Clean Seed Capital Group is working full tilt at driving technology advancements in farming. The Canadian company has created the CX-6 SMART Seeder, a machine with the ability to plant six different crops, at three different depths with military precision.
The beauty of the CX-6 SMART Seeder for farmers and agriculture scientists is that the hulking high-output planter is wirelessly controlled through a tablet running on the company’s intuitive SeedSync software system.
Clean Seed has not stopped with the CX-6 SMAT seeder, but has just rolled out a highly advanced, lighter version of its planter. The company teamed up with joint venture partner North Dakota-based Norwood to give farmers the new Smart Seeder Max and Smart Seeder Max S.
“This partnership optimizes our ability to deliver growth, rapidly and reliably with an invested partner. Our teams are also collaborating on several additional opportunities that will further differentiate our offerings,” according to Clean Seed CEO Graeme Lempriere.
Serving up profits
MamaMancini's Holdings, a specialty Italian food company known for its signature beef, turkey, chicken, and pork meatballs with slow-cooked Italian sauces, is expanding into plant-based products by teaming up with Beyond Meat Inc (NASDAQ:BYND).
East Rutherford, New Jersey-based MamaMancini's said it has seen strong sales as Americans stocked up on packaged food products during the coronavirus lockdown. The company offers 20 products sold through 45,000 stores, including Whole Foods and Costco (NASDAQ:COST).
“Consumers are looking for delicious, plant-based proteins and our meatballs are the perfect solution as Beyond Beef’s high quality, texture, taste and nutritional profile meet all major consumer expectations,” MamaMancini’s CEO Carl Wolf told Proactive.
“As the country returns to normal activities, we believe the trend toward plant-based options will continue to grow,” he added.
For its fiscal first quarter ended April 30, 2020, MamaMancini’s posted $11.1 million in revenue, a 51% jump, compared to $7.4 million in the same period a year earlier. Gross profit increased to $3.7 million, or 34% of total revenues, in the first quarter of 2021, compared to $2.4 million.
Embodiment of Americana
Alpine 4 Technologies Ltd (OTCQB:ALPP) is a technology holding company that provides electronic contract manufacturing solutions in the US. It has business ventures in automotive technologies, electronics manufacturing, fabrication technologies and clean energy solutions.
The Phoenix-based group acquires businesses that fit into its disruptive “DSF business model” of “drivers, stabilizers, and facilitators.” Alpine 4 believes its holdings should be synergistic and collaborate across various industries spawning new ideas and competitive advantages.
Alpine 4 Technologies CEO Kent Wilson said: "We are delighted to present at the Proactive Investors One2One event. Alpine 4 will be conducting a series of interviews, and roadshow events in July, August and September and this event will kick off our Q3 corporate awareness campaign."
“Alpine 4 is the embodiment of 'Americana.' Our products and services are made in the USA and we are proud of it," he added.
The company has issued preliminary second-quarter revenue guidance of around $8.8 million, which is a 36% jump compared to revenue of $5.64 million posted in the same period in 2019.
Proactive is one of the fastest-growing financial media portals in the world, providing breaking news and analysis on companies across the globe. Proactive regularly organizes large investor events in London, New York, and Sydney.
Contact the author Uttara Choudhury at [email protected]
Follow her on Twitter: @UttaraProactive